Table I.
Association between the expression of SUMO1P3 and the clinicopathological characteristics of patients with pancreatic cancer.
| SUMO1P3 expression, n | ||||
|---|---|---|---|---|
| Clinicopathological parameters | n | High | Low | P-value |
| 48 | 33 | 15 | ||
| Age, years | 0.633 | |||
| <60 | 19 | 12 | 7 | |
| ≥60 | 29 | 21 | 8 | |
| Sex | 0.416 | |||
| Female | 17 | 13 | 4 | |
| Male | 31 | 20 | 11 | |
| Tumor size, cm | 0.019 | |||
| <4 | 30 | 17 | 13 | |
| ≥4 | 18 | 16 | 2 | |
| Histological differentiation | 0.205 | |||
| Well and moderate | 33 | 21 | 12 | |
| Poor | 15 | 12 | 3 | |
| Location | 0.371 | |||
| Head-neck | 27 | 19 | 8 | |
| Body-tail | 21 | 14 | 7 | |
| Lymph node metastasis | 0.028 | |||
| Negative | 35 | 22 | 13 | |
| Positive | 13 | 11 | 2 | |
| TNM stage | 0.034 | |||
| I–II | 41 | 26 | 15 | |
| III | 7 | 7 | 0 | |
TNM, tumor-node metastasis; SUMO1P3, small ubiquitin-like modifier 1 pseudogene 3.